Episode 14 – Rapid Fire SARS-CoV-2 Vaccines

Welcome back Rounds Table Listeners!

This week we are going back to our Rapid Fire Format to review two papers looking at potential SARS-CoV-2 vaccines.

  1. What is the safety profile and immune system response for a novel SARS-CoV-2 specific vaccine? https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 (1:05-8:44)
  2. What is the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of SARS-CoV-2? https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext (8:45-20:31)

And for the Good Stuff:

  1. No further description needed, just a guy painting a portrait of himself, painting a portrait of himself, on repeat: https://digg.com/2020/guy-paints-himself-painting-himself-over-and-over
  2. A nice review on why we should drink coffee from NEJM: https://www.nejm.org/doi/full/10.1056/NEJMra1816604

Questions? Comments? Feedback? We’d love to hear from you. @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

1 Comment
  • Richard Fralick says:

    A short review on immunology, a reminder about the ‘lasting’ effect from the CD4 T cell response to an immunization, and an informative review of two vaccine studies, notably the one from the Oxford group. Thanks so much!

Republish this article

Republish this article on your website under the creative commons licence.

Learn more